(Q50777310)

19 March 2018

title

Serum amyloid A activates NF-kappaB and proinflammatory gene expression in human and murine intestinal epithelial cells. (English)

1 reference

19 March 2018

1 reference

Humberto B Jijon

1

1 reference

19 March 2018

Karen L Madsen

2

1 reference

19 March 2018

John W Walker

3

1 reference

19 March 2018

Brigitte Allard

4

1 reference

19 March 2018

Christian Jobin

5

1 reference

19 March 2018

language of work or name

English

0 references

publication date

1 March 2005

1 reference

19 March 2018

European Journal of Immunology

published in

1 reference

19 March 2018

volume

35

1 reference

19 March 2018

issue

3

1 reference

19 March 2018

page(s)

718-726

1 reference

19 March 2018

Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Serum amyloid A, the major vertebrate acute-phase reactant

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Influence of serum amyloid A on cholesterol esterification in human plasma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Serum amyloid A (SAA), a protein without a function: some suggestions with reference to cholesterol metabolism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

IL-10 gene therapy prevents TNBS-induced colitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Epithelial induction of serum amyloid A in experimental mucosal inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Identification of genes involved in mucosal defense and inflammation associated with normal enteric bacteria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Distinct inflammatory mechanisms mediate early versus late colitis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

rHuKGF ameliorates symptoms in DSS and CD4(+)CD45RB(Hi) T cell transfer mouse models of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Serum amyloid A induces chemotaxis of human mast cells by activating a pertussis toxin-sensitive signal transduction pathway.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Serum amyloid A is an activator of PMN antimicrobial functions: induction of degranulation, phagocytosis, and enhancement of anti-Candida activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Acute-phase, but not constitutive serum amyloid A (SAA) is chemotactic for cultured human aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Expression and regulation of constitutive and acute phase serum amyloid A mRNAs in hepatic and non-hepatic cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Human serum amyloid A3 peptide enhances intestinal MUC3 expression and inhibits EPEC adherence.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

NF-kappaB signaling proteins as therapeutic targets for inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

AP-1 as a regulator of cell life and death

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

MAP kinases contribute to IL-8 secretion by intestinal epithelial cells via a posttranscriptional mechanism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

ERK and p38 inhibit the expression of 4E-BP1 repressor of translation through induction of Egr-1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

The IKK NF-kappa B system: a treasure trove for drug development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Review article: COX-2, prostanoids and colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425688

7 January 2021

Identifiers

DOI

10.1002/EJI.200425688

1 reference

19 March 2018

release_pmyelgh2ybblzhatauuft47atu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pmyelgh2ybblzhatauuft47atu

24 November 2022

mapped directly with Wikidata item

1 reference

19 March 2018